SCHEMBL9142328

SCHEMBL9142328

CS(=O)(=O)c1ccc(NC(=O)c2ccccc2Br)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 4/20 0.67
▸ RAB9A P51151 4/20 0.67
▸ KMT2A Q03164 5/20 0.63
▸ MEN1 O00255 2/20 0.63
▸ SMN1; SMN2 Q16637 4/20 0.62
▸ ALDH1A1 P00352 3/20 0.62
▸ KDM4E B2RXH2 1/20 0.57
▸ BCAT2 O15382 1/20 0.55
▸ AVPR2 P30518 1/20 0.55
▸ GPR27 Q9NS67 1/20 0.55
▸ TSHR P16473 1/20 0.54
▸ LMNA P02545 2/20 0.54
▸ MAOA P21397 1/20 0.54
▸ MAOB P27338 1/20 0.54
▸ CA1 P00915 2/20 0.54
▸ CA2 P00918 2/20 0.54
▸ CA9 Q16790 2/20 0.54
▸ CA12 O43570 1/20 0.54
▸ CA5A P35218 1/20 0.54
▸ CA5B Q9Y2D0 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13454572 0.86 ALDH1A1 (0.59) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL11637300 0.85 GPR27 (0.63) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL2701214 0.83 LMNA (0.67) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL882781 0.81 NPC1 (0.75) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL8060238 0.81 NPC1 (0.75) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL8665327 0.81 CA1 (0.74) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL882734 0.80 KMT2A (0.80) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL1380321 0.78 MAPT (0.53) RAB9AKMT2AMEN1SMN1; SMN2ALDH1A1
SCHEMBL5569673 0.78 NPC1 (0.75) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL882776 0.78 NPC1 (0.75) NPC1RAB9AKMT2AMEN1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5420292-A Biphenyl-tetrazole intermediate compounds ZENECA LIMITED (GB) 1995-05-30 — — US disclosed
US-5294716-A Chemical process for making angiotesin II antagonist compounds IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1994-03-15 — — US disclosed
EP-0495626-A1 Process for the preparation of tetrazole derivatives ZENECA LIMITED (GB) 1992-07-22 — — EP disclosed
Send feedback